Raymond James Financial Services Advisors’s CVS Health CVS Stock Holding History

Raymond James Financial Services Advisors’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-14,900	Closed	-$447	–	3290
2022 Q4	$447	Hold	14,900	–	–	﹤0.01%	3248
2022 Q3	$4K	Sell	14,900 -4,800	-24%	-$475K	﹤0.01%	3234
2022 Q2	$1K	Buy	+19,700	New	+$1.92M	﹤0.01%	3246
2021 Q4	–	Sell	-12,200	Closed	-$40K	–	3340
2021 Q3	$40K	Sell	12,200 -14,500	-54%	-$1.21M	﹤0.01%	3199
2021 Q2	$41K	Buy	+26,700	New	+$2.19M	﹤0.01%	3224
2021 Q1	–	Sell	-26,700	Closed	-$3K	–	3198
2020 Q4	$3K	Buy	26,700 +14,600	+121%	+$950K	﹤0.01%	2980
2020 Q3	$1K	Buy	+12,100	New	+$753K	﹤0.01%	2874
2020 Q1	–	Sell	-23,600	Closed	-$20K	–	2485
2019 Q4	$20K	Buy	+23,600	New	+$1.66M	﹤0.01%	2802

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Raymond James Financial Services Advisors's CVS Position: Q3 2024 in Review

Raymond James Financial Services Advisors reduced its CVS Health (CVS) stake by 15% in Q3 2024, selling an estimated $10.6M and leaving 1,017,467 shares worth $64M. The position accounts for 0.09% of the portfolio, ranked #229.

Raymond James Financial Services Advisors first reported a position in CVS in Q2 2013 and has held it in 46 quarters since. The position peaked at $193M in Q4 2021. 1,842 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

Raymond James Financial Services Advisors held 1,017,467 shares of CVS Health worth $64M as of Q3 2024.
Raymond James Financial Services Advisors sold 181,687 CVS Health shares in Q3 2024, an estimated $10.6M.
CVS Health made up 0.09% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #229 holding.
Raymond James Financial Services Advisors first reported a position in CVS Health in Q2 2013 and has held it in 46 quarters since.
Raymond James Financial Services Advisors's CVS Health position peaked at $193M in Q4 2021.
1,842 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.